Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

Regeneron Pharmaceuticals moved higher after promising results from a clinical trial of Dupixent for the treatment of a rare ...

Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...

The model used to summarize this release may make ... Phase 1b head-to-head study vs. DUPIXENT supported by successful completion of preclinical combination toxicology studies and positive APG990 ...

We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Large Language Models (LLMs) are advanced AI systems trained on vast amounts of text ...

Please view our affiliate disclosure. Improved large language models (LLMs) emerge frequently, and while cloud-based solutions offer convenience, running LLMs locally provides several advantages, ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

Around the world, the biggest players in LLM technology are coming out with new versions of their models at staggering speed. But how do they stack up? Analyst and testers (and others) are coming ...

Photo by Tayfun Coskun/Anadolu via Getty Images The European Center for Medium-Range Weather Forecasts (ECMWF) just launched an AI-powered forecasting model, which the center says outperforms ...